

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.61934743 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.61934743 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.50737320 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.15761873 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.15761873 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06060127 |
| 7 | detection of other organism (GO:0098543) | 3.81270924 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.78922408 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.78922408 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.78922408 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 3.78922408 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 3.78922408 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.78922408 |
| 14 | detection of bacterium (GO:0016045) | 3.68143372 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 3.67573362 |
| 16 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.65745183 |
| 17 | response to peptidoglycan (GO:0032494) | 3.63912341 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 3.61229966 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 3.60271217 |
| 20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.60101073 |
| 21 | * immunoglobulin mediated immune response (GO:0016064) | 3.54799519 |
| 22 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.51737131 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.50513302 |
| 24 | response to type I interferon (GO:0034340) | 3.44355400 |
| 25 | cellular response to type I interferon (GO:0071357) | 3.43410615 |
| 26 | type I interferon signaling pathway (GO:0060337) | 3.43410615 |
| 27 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.43303178 |
| 28 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.41845148 |
| 29 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.40187450 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.32556676 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.32245051 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 3.30361859 |
| 33 | positive regulation of humoral immune response (GO:0002922) | 3.24983820 |
| 34 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.24000306 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 3.20551537 |
| 36 | regulation of vitamin metabolic process (GO:0030656) | 3.20016500 |
| 37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.16982367 |
| 38 | positive regulation of type 2 immune response (GO:0002830) | 3.14643282 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.13193115 |
| 40 | regulation of antigen processing and presentation (GO:0002577) | 3.09478734 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.09273081 |
| 42 | * B cell mediated immunity (GO:0019724) | 3.08097862 |
| 43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.07212096 |
| 44 | tolerance induction (GO:0002507) | 3.06258538 |
| 45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05100160 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 3.04476845 |
| 47 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.00056537 |
| 48 | myeloid dendritic cell differentiation (GO:0043011) | 2.97479287 |
| 49 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.96489503 |
| 50 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.95764523 |
| 51 | detection of biotic stimulus (GO:0009595) | 2.95072220 |
| 52 | regulation of T cell tolerance induction (GO:0002664) | 2.95065708 |
| 53 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.94901966 |
| 54 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94829199 |
| 55 | neutrophil activation (GO:0042119) | 2.94269791 |
| 56 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.93448764 |
| 57 | macrophage activation (GO:0042116) | 2.92106709 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 2.84243226 |
| 59 | regulation of type 2 immune response (GO:0002828) | 2.83180068 |
| 60 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.82870134 |
| 61 | * germinal center formation (GO:0002467) | 2.82829822 |
| 62 | macrophage activation involved in immune response (GO:0002281) | 2.81364738 |
| 63 | T cell migration (GO:0072678) | 2.80923724 |
| 64 | positive regulation of interferon-beta production (GO:0032728) | 2.80456592 |
| 65 | regulation of response to interferon-gamma (GO:0060330) | 2.78184225 |
| 66 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.77645592 |
| 67 | leukocyte aggregation (GO:0070486) | 2.76785814 |
| 68 | regulation of podosome assembly (GO:0071801) | 2.76388558 |
| 69 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.76194129 |
| 70 | negative regulation of interleukin-6 production (GO:0032715) | 2.75995166 |
| 71 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.75665270 |
| 72 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.74068170 |
| 73 | cellular extravasation (GO:0045123) | 2.73907282 |
| 74 | response to interferon-beta (GO:0035456) | 2.73510807 |
| 75 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.73029960 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71579445 |
| 77 | myeloid dendritic cell activation (GO:0001773) | 2.70088677 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 2.70042488 |
| 79 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.69504370 |
| 80 | regulation of tolerance induction (GO:0002643) | 2.69258931 |
| 81 | regulation of mast cell degranulation (GO:0043304) | 2.68494727 |
| 82 | cellular response to virus (GO:0098586) | 2.65468080 |
| 83 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.64528729 |
| 84 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.63895807 |
| 85 | respiratory burst (GO:0045730) | 2.63115884 |
| 86 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.62928952 |
| 87 | interferon-gamma secretion (GO:0072643) | 2.62639139 |
| 88 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.61322892 |
| 89 | negative regulation of innate immune response (GO:0045824) | 2.60509683 |
| 90 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.60225843 |
| 91 | dendritic cell differentiation (GO:0097028) | 2.59170943 |
| 92 | response to host immune response (GO:0052572) | 2.58813473 |
| 93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.58813473 |
| 94 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.58580317 |
| 95 | negative regulation of T cell mediated immunity (GO:0002710) | 2.56827474 |
| 96 | regulation of interleukin-12 production (GO:0032655) | 2.56616622 |
| 97 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56006101 |
| 98 | regulation of chronic inflammatory response (GO:0002676) | 2.55462405 |
| 99 | response to interferon-gamma (GO:0034341) | 2.54980796 |
| 100 | low-density lipoprotein particle clearance (GO:0034383) | 2.54845000 |
| 101 | regulation of superoxide anion generation (GO:0032928) | 2.54679791 |
| 102 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.53429463 |
| 103 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.53035454 |
| 104 | cellular response to lipopolysaccharide (GO:0071222) | 2.52914860 |
| 105 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.52802460 |
| 106 | positive regulation of B cell mediated immunity (GO:0002714) | 2.52802460 |
| 107 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.52638206 |
| 108 | regulation of interleukin-6 production (GO:0032675) | 2.52222011 |
| 109 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.51580910 |
| 110 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.51393741 |
| 111 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.51207113 |
| 112 | cellular response to molecule of bacterial origin (GO:0071219) | 2.50791694 |
| 113 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.50191822 |
| 114 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.50152521 |
| 115 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.49904881 |
| 116 | acute-phase response (GO:0006953) | 2.48533243 |
| 117 | protein carboxylation (GO:0018214) | 2.48236456 |
| 118 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.48236456 |
| 119 | cellular response to interferon-gamma (GO:0071346) | 2.47395548 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 2.47231761 |
| 121 | * positive regulation of cytokine biosynthetic process (GO:0042108) | 2.46636540 |
| 122 | regulation of B cell differentiation (GO:0045577) | 2.46343185 |
| 123 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.46334698 |
| 124 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.46305669 |
| 125 | positive regulation of antigen processing and presentation (GO:0002579) | 2.45938445 |
| 126 | granulocyte activation (GO:0036230) | 2.45308694 |
| 127 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.44058927 |
| 128 | positive regulation of interleukin-12 production (GO:0032735) | 2.43893326 |
| 129 | regulation of cholesterol storage (GO:0010885) | 2.43529980 |
| 130 | regulation of chemokine biosynthetic process (GO:0045073) | 2.42653059 |
| 131 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.42551437 |
| 132 | negative regulation of growth of symbiont in host (GO:0044130) | 2.42486911 |
| 133 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.42486911 |
| 134 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.42486911 |
| 135 | regulation of growth of symbiont in host (GO:0044126) | 2.42486911 |
| 136 | * defense response to protozoan (GO:0042832) | 2.42378997 |
| 137 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.41588470 |
| 138 | response to interferon-alpha (GO:0035455) | 2.41023904 |
| 139 | response to host (GO:0075136) | 2.40470707 |
| 140 | response to host defenses (GO:0052200) | 2.40470707 |
| 141 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.40470707 |
| 142 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.39362565 |
| 143 | complement activation, alternative pathway (GO:0006957) | 2.38730430 |
| 144 | negative regulation of viral genome replication (GO:0045071) | 2.38367833 |
| 145 | * response to protozoan (GO:0001562) | 2.38180086 |
| 146 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.38167351 |
| 147 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.37879016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.50258928 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.50257274 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.50107968 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.44472186 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.92688353 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88708740 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.75908046 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.71855384 |
| 9 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.70991950 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.68777354 |
| 11 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59265903 |
| 12 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.54029816 |
| 13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.49104927 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.42426072 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39783344 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.35809799 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33503157 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30830860 |
| 19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.28675976 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.28230077 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.22996943 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16081365 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.13482269 |
| 24 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05205704 |
| 25 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03917193 |
| 26 | * STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.03612762 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.99882442 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.96950412 |
| 29 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90588029 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84279573 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.79818496 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72370028 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.71278991 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69740785 |
| 35 | * MYB_26560356_Chip-Seq_TH2_Human | 1.68775075 |
| 36 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68086424 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.64327623 |
| 38 | * MYB_26560356_Chip-Seq_TH1_Human | 1.64285717 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.64046571 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62107085 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61318161 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60732812 |
| 43 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.59452762 |
| 44 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57136225 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56689783 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56518631 |
| 47 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55580716 |
| 48 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54989346 |
| 49 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.52321178 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51624414 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51124535 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50704094 |
| 53 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49920464 |
| 54 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49423155 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44441694 |
| 56 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34800106 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31816329 |
| 58 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31450407 |
| 59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.30224229 |
| 60 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.29226641 |
| 61 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.29226641 |
| 62 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.29226641 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28265755 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27732993 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.26386837 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23823440 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22770966 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21118309 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18742690 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18324232 |
| 71 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.17643986 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16970599 |
| 73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16788150 |
| 74 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15810365 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15180438 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14745634 |
| 77 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.13148956 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12599156 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12533447 |
| 80 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.12475244 |
| 81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12295833 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10839396 |
| 83 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.10832053 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10523272 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10234196 |
| 86 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09647170 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08886951 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08451136 |
| 89 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06385249 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05557403 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04151399 |
| 92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03896653 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03088757 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02029257 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01949672 |
| 96 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01138976 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99449289 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98737714 |
| 99 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98188184 |
| 100 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.98041157 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96472687 |
| 102 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96317680 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95924357 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95602792 |
| 105 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95425116 |
| 106 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95307007 |
| 107 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94353572 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93969456 |
| 109 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93878421 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93823702 |
| 111 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93733828 |
| 112 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93646964 |
| 113 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93384827 |
| 114 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92973489 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91979061 |
| 116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89491469 |
| 117 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88286711 |
| 118 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.86897162 |
| 119 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86607862 |
| 120 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86502811 |
| 121 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85994005 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83377465 |
| 123 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83277073 |
| 124 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81940588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.35578027 |
| 2 | MP0003436_decreased_susceptibility_to | 3.24464395 |
| 3 | MP0003303_peritoneal_inflammation | 3.15217410 |
| 4 | MP0009785_altered_susceptibility_to | 2.96653043 |
| 5 | MP0000685_abnormal_immune_system | 2.87044794 |
| 6 | MP0001790_abnormal_immune_system | 2.64893713 |
| 7 | MP0005387_immune_system_phenotype | 2.64893713 |
| 8 | * MP0001800_abnormal_humoral_immune | 2.45282804 |
| 9 | MP0003724_increased_susceptibility_to | 2.43382818 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.42546840 |
| 11 | * MP0005025_abnormal_response_to | 2.39739043 |
| 12 | MP0009840_abnormal_foam_cell | 2.28533597 |
| 13 | MP0005360_urolithiasis | 2.25000559 |
| 14 | MP0005671_abnormal_response_to | 2.24283431 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.22815995 |
| 16 | MP0006082_CNS_inflammation | 2.22376645 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.17302295 |
| 18 | * MP0002452_abnormal_antigen_presenting | 2.14679812 |
| 19 | MP0005451_abnormal_body_composition | 2.14059404 |
| 20 | MP0004510_myositis | 2.13988776 |
| 21 | * MP0002419_abnormal_innate_immunity | 2.12292398 |
| 22 | MP0001853_heart_inflammation | 2.12061453 |
| 23 | * MP0002723_abnormal_immune_serum | 2.09847426 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 2.01938703 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.01794719 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 1.97744087 |
| 27 | MP0004947_skin_inflammation | 1.93673320 |
| 28 | * MP0001819_abnormal_immune_cell | 1.83505922 |
| 29 | * MP0002420_abnormal_adaptive_immunity | 1.82776111 |
| 30 | MP0002405_respiratory_system_inflammati | 1.80542795 |
| 31 | MP0009278_abnormal_bone_marrow | 1.75978767 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.72984696 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.70844295 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.69376395 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.65086989 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.64606732 |
| 37 | MP0008004_abnormal_stomach_pH | 1.64404755 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.63800487 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.63510349 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.59180236 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.59180236 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.58256477 |
| 43 | MP0008469_abnormal_protein_level | 1.56726769 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.54183206 |
| 45 | * MP0002398_abnormal_bone_marrow | 1.53101673 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.51219832 |
| 47 | * MP0000716_abnormal_immune_system | 1.49789321 |
| 48 | MP0009764_decreased_sensitivity_to | 1.46370076 |
| 49 | MP0005365_abnormal_bile_salt | 1.45959247 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.45315791 |
| 51 | MP0002006_tumorigenesis | 1.44041250 |
| 52 | MP0002254_reproductive_system_inflammat | 1.43370276 |
| 53 | MP0003448_altered_tumor_morphology | 1.42679226 |
| 54 | MP0001873_stomach_inflammation | 1.42672666 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.38411956 |
| 56 | * MP0000689_abnormal_spleen_morphology | 1.37863156 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.34683239 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34378116 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.32966299 |
| 60 | MP0000609_abnormal_liver_physiology | 1.32620460 |
| 61 | MP0008260_abnormal_autophagy | 1.29997270 |
| 62 | * MP0002722_abnormal_immune_system | 1.29563109 |
| 63 | MP0003866_abnormal_defecation | 1.28357602 |
| 64 | * MP0002429_abnormal_blood_cell | 1.26941169 |
| 65 | MP0005023_abnormal_wound_healing | 1.24283481 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.19569037 |
| 67 | MP0000490_abnormal_crypts_of | 1.16519320 |
| 68 | MP0000343_altered_response_to | 1.15368896 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.12461502 |
| 70 | MP0005164_abnormal_response_to | 1.10451614 |
| 71 | MP0002332_abnormal_exercise_endurance | 1.09377801 |
| 72 | MP0003252_abnormal_bile_duct | 1.09189041 |
| 73 | MP0000858_altered_metastatic_potential | 1.08445600 |
| 74 | MP0005058_abnormal_lysosome_morphology | 1.07909182 |
| 75 | * MP0009763_increased_sensitivity_to | 1.06390560 |
| 76 | MP0001663_abnormal_digestive_system | 1.04139889 |
| 77 | MP0002933_joint_inflammation | 1.03458799 |
| 78 | MP0005310_abnormal_salivary_gland | 1.02545821 |
| 79 | MP0010307_abnormal_tumor_latency | 1.02301452 |
| 80 | MP0003091_abnormal_cell_migration | 1.01957376 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 1.01932800 |
| 82 | MP0003075_altered_response_to | 1.00830017 |
| 83 | MP0010329_abnormal_lipoprotein_level | 1.00558710 |
| 84 | MP0005083_abnormal_biliary_tract | 0.99521333 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.97652516 |
| 86 | MP0004858_abnormal_nervous_system | 0.96832781 |
| 87 | MP0005166_decreased_susceptibility_to | 0.96324467 |
| 88 | MP0000598_abnormal_liver_morphology | 0.93289399 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 0.91340535 |
| 90 | MP0003690_abnormal_glial_cell | 0.91231746 |
| 91 | MP0003186_abnormal_redox_activity | 0.91185902 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.89463956 |
| 93 | MP0006054_spinal_hemorrhage | 0.89318459 |
| 94 | MP0004883_abnormal_blood_vessel | 0.88954540 |
| 95 | MP0000249_abnormal_blood_vessel | 0.85667911 |
| 96 | MP0001851_eye_inflammation | 0.85394231 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.84961385 |
| 98 | MP0003828_pulmonary_edema | 0.83853149 |
| 99 | MP0001666_abnormal_nutrient_absorption | 0.83413324 |
| 100 | MP0001542_abnormal_bone_strength | 0.81891235 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 0.81290430 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.78688083 |
| 103 | MP0002019_abnormal_tumor_incidence | 0.78401648 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 0.76052272 |
| 105 | MP0002132_abnormal_respiratory_system | 0.74837854 |
| 106 | MP0003795_abnormal_bone_structure | 0.72273182 |
| 107 | MP0003045_fibrosis | 0.71891785 |
| 108 | MP0000604_amyloidosis | 0.71743395 |
| 109 | MP0005390_skeleton_phenotype | 0.71046335 |
| 110 | MP0008874_decreased_physiological_sensi | 0.70844907 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.70569398 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.70364011 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.70326773 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.69042168 |
| 115 | MP0008873_increased_physiological_sensi | 0.69030625 |
| 116 | MP0005381_digestive/alimentary_phenotyp | 0.68997460 |
| 117 | MP0000477_abnormal_intestine_morphology | 0.68416758 |
| 118 | MP0005165_increased_susceptibility_to | 0.68166260 |
| 119 | MP0003279_aneurysm | 0.67484830 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.67338131 |
| 121 | MP0005332_abnormal_amino_acid | 0.65939027 |
| 122 | MP0004019_abnormal_vitamin_homeostasis | 0.65914414 |
| 123 | MP0001849_ear_inflammation | 0.65871849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.04043210 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.58257673 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.44067311 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.44067311 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.44067311 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.28752623 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.16924498 |
| 8 | Myositis (HP:0100614) | 4.11899460 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.05092767 |
| 10 | Orchitis (HP:0100796) | 3.67655722 |
| 11 | Pustule (HP:0200039) | 3.47443400 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 3.45365713 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.44332530 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.39517337 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.38492407 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.35527684 |
| 17 | Loss of speech (HP:0002371) | 3.34365272 |
| 18 | Interstitial pulmonary disease (HP:0006530) | 3.22010898 |
| 19 | Vasculitis (HP:0002633) | 3.21211859 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.19493663 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 3.18853879 |
| 22 | Gingival bleeding (HP:0000225) | 3.17372318 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.02198339 |
| 24 | Optic neuritis (HP:0100653) | 3.02198339 |
| 25 | Myocardial infarction (HP:0001658) | 3.01149901 |
| 26 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.99178002 |
| 27 | Stomatitis (HP:0010280) | 2.99057402 |
| 28 | IgM deficiency (HP:0002850) | 2.93474813 |
| 29 | Recurrent skin infections (HP:0001581) | 2.93071056 |
| 30 | Deep venous thrombosis (HP:0002625) | 2.88215499 |
| 31 | Recurrent viral infections (HP:0004429) | 2.86006769 |
| 32 | Malnutrition (HP:0004395) | 2.85226761 |
| 33 | Nasal polyposis (HP:0100582) | 2.84561826 |
| 34 | Spontaneous hematomas (HP:0007420) | 2.81242470 |
| 35 | Recurrent bronchitis (HP:0002837) | 2.79726335 |
| 36 | Complement deficiency (HP:0004431) | 2.77343185 |
| 37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.75279876 |
| 38 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.75279876 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.75279876 |
| 40 | Increased IgE level (HP:0003212) | 2.75130183 |
| 41 | Joint hemorrhage (HP:0005261) | 2.74954395 |
| 42 | Chronic otitis media (HP:0000389) | 2.72178963 |
| 43 | Abnormality of the nasal mucosa (HP:0000433) | 2.71883511 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70250423 |
| 45 | Cellulitis (HP:0100658) | 2.69631788 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 2.65913813 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.64629811 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.64087946 |
| 49 | Xanthomatosis (HP:0000991) | 2.62306019 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.61263989 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61263989 |
| 52 | Abnormality of complement system (HP:0005339) | 2.60608182 |
| 53 | Urticaria (HP:0001025) | 2.59580163 |
| 54 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.59105938 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.54841620 |
| 56 | Gingivitis (HP:0000230) | 2.54016426 |
| 57 | Colitis (HP:0002583) | 2.52822234 |
| 58 | Disinhibition (HP:0000734) | 2.51827236 |
| 59 | Anorexia (HP:0002039) | 2.51642214 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.51269102 |
| 61 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.49902587 |
| 62 | Intrahepatic cholestasis (HP:0001406) | 2.48188635 |
| 63 | Increased serum ferritin (HP:0003281) | 2.47841872 |
| 64 | Meningitis (HP:0001287) | 2.47761768 |
| 65 | Increased IgM level (HP:0003496) | 2.46329513 |
| 66 | Gangrene (HP:0100758) | 2.45218614 |
| 67 | Arterial thrombosis (HP:0004420) | 2.44588461 |
| 68 | Esophageal varix (HP:0002040) | 2.43065712 |
| 69 | Vacuolated lymphocytes (HP:0001922) | 2.38309832 |
| 70 | Axonal loss (HP:0003447) | 2.38221365 |
| 71 | Abnormality of T cells (HP:0002843) | 2.37777282 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.37079034 |
| 73 | Epistaxis (HP:0000421) | 2.33009485 |
| 74 | Joint swelling (HP:0001386) | 2.31288773 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31105811 |
| 76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31105811 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.30574575 |
| 78 | Peritonitis (HP:0002586) | 2.28962706 |
| 79 | Nuclear cataract (HP:0100018) | 2.26855475 |
| 80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.25498431 |
| 81 | Obstructive lung disease (HP:0006536) | 2.25498431 |
| 82 | Hemoptysis (HP:0002105) | 2.24987763 |
| 83 | Hypergammaglobulinemia (HP:0010702) | 2.24577865 |
| 84 | Periodontitis (HP:0000704) | 2.23815253 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 2.22637094 |
| 86 | Thin bony cortex (HP:0002753) | 2.21642722 |
| 87 | Episodic fever (HP:0001954) | 2.21543724 |
| 88 | Hypobetalipoproteinemia (HP:0003563) | 2.21413889 |
| 89 | Petechiae (HP:0000967) | 2.18743188 |
| 90 | Pulmonary embolism (HP:0002204) | 2.18394146 |
| 91 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.14458090 |
| 92 | IgA deficiency (HP:0002720) | 2.14031717 |
| 93 | Encephalitis (HP:0002383) | 2.13135185 |
| 94 | Abnormality of the pleura (HP:0002103) | 2.12640745 |
| 95 | Glomerulonephritis (HP:0000099) | 2.09929530 |
| 96 | Thrombophlebitis (HP:0004418) | 2.09257227 |
| 97 | Acne (HP:0001061) | 2.08301915 |
| 98 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.08283996 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 2.07797795 |
| 100 | Amyloidosis (HP:0011034) | 2.07531089 |
| 101 | Abnormality of T cell number (HP:0011839) | 2.07045156 |
| 102 | Thrombocytosis (HP:0001894) | 2.06204403 |
| 103 | Abnormality of the pericardium (HP:0001697) | 2.05122554 |
| 104 | Cheilitis (HP:0100825) | 2.04335770 |
| 105 | Keratoconjunctivitis (HP:0001096) | 2.04321258 |
| 106 | Hepatosplenomegaly (HP:0001433) | 2.04264216 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.04156461 |
| 108 | Purpura (HP:0000979) | 2.03045140 |
| 109 | Prolonged partial thromboplastin time (HP:0003645) | 2.02791613 |
| 110 | Skin ulcer (HP:0200042) | 2.02420345 |
| 111 | Hypochromic anemia (HP:0001931) | 2.00384075 |
| 112 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.99867763 |
| 113 | Polycythemia (HP:0001901) | 1.99491726 |
| 114 | Hematochezia (HP:0002573) | 1.99414675 |
| 115 | Emphysema (HP:0002097) | 1.98807748 |
| 116 | Polygenic inheritance (HP:0010982) | 1.97413813 |
| 117 | Restrictive lung disease (HP:0002091) | 1.97143342 |
| 118 | Neurofibrillary tangles (HP:0002185) | 1.96624799 |
| 119 | Leukocytosis (HP:0001974) | 1.96565492 |
| 120 | Thoracic kyphosis (HP:0002942) | 1.96456943 |
| 121 | Premature loss of primary teeth (HP:0006323) | 1.96131209 |
| 122 | Progressive neurologic deterioration (HP:0002344) | 1.95412994 |
| 123 | T lymphocytopenia (HP:0005403) | 1.95160504 |
| 124 | Chest pain (HP:0100749) | 1.94936541 |
| 125 | Nephritis (HP:0000123) | 1.93506495 |
| 126 | Aplastic anemia (HP:0001915) | 1.93054417 |
| 127 | Glomerulopathy (HP:0100820) | 1.92474765 |
| 128 | Abnormal platelet volume (HP:0011876) | 1.91754564 |
| 129 | Arthralgia (HP:0002829) | 1.90125391 |
| 130 | Polyneuropathy (HP:0001271) | 1.89951628 |
| 131 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89638058 |
| 132 | Prolonged bleeding time (HP:0003010) | 1.88540301 |
| 133 | Hemorrhage of the eye (HP:0011885) | 1.88366686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.88711226 |
| 2 | MAP4K1 | 3.74636292 |
| 3 | MAP3K14 | 3.15380883 |
| 4 | TYK2 | 2.99660139 |
| 5 | TBK1 | 2.94670701 |
| 6 | FGFR4 | 2.81408084 |
| 7 | PRPF4B | 2.66915059 |
| 8 | JAK3 | 2.59321455 |
| 9 | IRAK3 | 2.51718254 |
| 10 | BLK | 2.31865546 |
| 11 | EPHB1 | 2.19637375 |
| 12 | IKBKE | 2.17469198 |
| 13 | TXK | 2.10542676 |
| 14 | TAOK2 | 2.09956955 |
| 15 | IKBKB | 1.93635582 |
| 16 | IRAK4 | 1.90477005 |
| 17 | TRIB3 | 1.89694437 |
| 18 | MAP3K10 | 1.87461932 |
| 19 | JAK1 | 1.85166577 |
| 20 | EPHA3 | 1.84696679 |
| 21 | ZAP70 | 1.80158004 |
| 22 | CSK | 1.75781484 |
| 23 | CDK12 | 1.70394990 |
| 24 | PIM2 | 1.65409417 |
| 25 | GRK6 | 1.63430763 |
| 26 | CDC42BPA | 1.54612796 |
| 27 | STK10 | 1.53864935 |
| 28 | CHUK | 1.51906703 |
| 29 | KIT | 1.50605405 |
| 30 | GRK7 | 1.44679247 |
| 31 | BTK | 1.43394542 |
| 32 | RPS6KA4 | 1.43226191 |
| 33 | PKN2 | 1.42763287 |
| 34 | NME2 | 1.40463958 |
| 35 | DDR2 | 1.40237990 |
| 36 | TAOK3 | 1.32900806 |
| 37 | PIM1 | 1.29819637 |
| 38 | FGFR3 | 1.26257144 |
| 39 | CSF1R | 1.25956135 |
| 40 | FLT3 | 1.24405710 |
| 41 | HCK | 1.23422931 |
| 42 | MST4 | 1.20598442 |
| 43 | MAP2K3 | 1.20389681 |
| 44 | KDR | 1.16765840 |
| 45 | JAK2 | 1.14304367 |
| 46 | IRAK2 | 1.13436783 |
| 47 | RIPK4 | 1.11204677 |
| 48 | TGFBR2 | 1.10856108 |
| 49 | MATK | 1.10580706 |
| 50 | NLK | 1.10080197 |
| 51 | PTK6 | 1.09960121 |
| 52 | RIPK1 | 1.09401189 |
| 53 | SIK1 | 1.08885460 |
| 54 | MAP3K11 | 1.08526168 |
| 55 | LRRK2 | 1.07080166 |
| 56 | LCK | 1.06500522 |
| 57 | SYK | 1.05269928 |
| 58 | BMX | 1.02991280 |
| 59 | MAP3K13 | 1.00884261 |
| 60 | SMG1 | 0.96277679 |
| 61 | BMPR2 | 0.93508933 |
| 62 | MOS | 0.84507209 |
| 63 | ITK | 0.84500316 |
| 64 | PRKD2 | 0.83497383 |
| 65 | MARK2 | 0.81711678 |
| 66 | MAP3K3 | 0.80833119 |
| 67 | LYN | 0.79557264 |
| 68 | TEC | 0.79165640 |
| 69 | ALK | 0.77852553 |
| 70 | IRAK1 | 0.72329357 |
| 71 | EPHA2 | 0.72023218 |
| 72 | PDPK1 | 0.70283702 |
| 73 | CDK6 | 0.69999278 |
| 74 | MST1R | 0.69815638 |
| 75 | TESK1 | 0.69694991 |
| 76 | CDK4 | 0.66668116 |
| 77 | MARK3 | 0.63889801 |
| 78 | MAPK7 | 0.61038017 |
| 79 | PRKG2 | 0.60750668 |
| 80 | PDK1 | 0.60043637 |
| 81 | PAK4 | 0.59395707 |
| 82 | ICK | 0.58766150 |
| 83 | RPS6KL1 | 0.57765166 |
| 84 | RPS6KC1 | 0.57765166 |
| 85 | FGR | 0.56571418 |
| 86 | BCKDK | 0.55701873 |
| 87 | MAP2K2 | 0.55436925 |
| 88 | HIPK2 | 0.54411803 |
| 89 | KSR2 | 0.54075395 |
| 90 | MAP3K6 | 0.53745465 |
| 91 | MAP2K6 | 0.53362386 |
| 92 | EGFR | 0.51957795 |
| 93 | ABL2 | 0.51738803 |
| 94 | MAP3K1 | 0.50656518 |
| 95 | MAP3K8 | 0.50321627 |
| 96 | FES | 0.49046542 |
| 97 | EEF2K | 0.48823491 |
| 98 | SIK3 | 0.48664072 |
| 99 | MAPK11 | 0.47735015 |
| 100 | SIK2 | 0.46807371 |
| 101 | MAPKAPK2 | 0.45688256 |
| 102 | CDK7 | 0.44385782 |
| 103 | ABL1 | 0.44213305 |
| 104 | TESK2 | 0.42272567 |
| 105 | RPS6KA2 | 0.41982085 |
| 106 | MAP3K5 | 0.40506335 |
| 107 | TGFBR1 | 0.40312317 |
| 108 | PDGFRA | 0.39066732 |
| 109 | PRKCD | 0.38649524 |
| 110 | ERBB4 | 0.37760848 |
| 111 | RPS6KA6 | 0.36267519 |
| 112 | TAOK1 | 0.35787572 |
| 113 | FYN | 0.35775293 |
| 114 | MAPK4 | 0.35563587 |
| 115 | NEK2 | 0.34897726 |
| 116 | MAPK12 | 0.33247355 |
| 117 | NEK9 | 0.32460244 |
| 118 | TNK2 | 0.31673581 |
| 119 | PTK2 | 0.30788282 |
| 120 | RPS6KA1 | 0.30350763 |
| 121 | PDGFRB | 0.29774806 |
| 122 | ACVR1B | 0.29412054 |
| 123 | MTOR | 0.28871569 |
| 124 | CAMK1D | 0.27754425 |
| 125 | MAP3K7 | 0.24651202 |
| 126 | DYRK1B | 0.24519127 |
| 127 | TTN | 0.23194753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.90476122 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72361083 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.48879881 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.18434273 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.13127207 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99587327 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.98025892 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.97226431 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.96380795 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95904270 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.92296039 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.88922707 |
| 13 | Asthma_Homo sapiens_hsa05310 | 1.85995401 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.84283657 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83727262 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81327396 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.77160470 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76414608 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.73852531 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.70758818 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68821748 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63892830 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.56067388 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55994235 |
| 25 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.54692589 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54583636 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.50388716 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.49724199 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48474678 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46542267 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45554143 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.27541282 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.25975193 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23371050 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.23157211 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22837738 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22640373 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.16990064 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.16833081 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13544965 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.09870472 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08753343 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08089855 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07781157 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07720522 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05768539 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.05090270 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02516792 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01822673 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.99136237 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.91678936 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91586273 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91365188 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.88953484 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87626762 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87546622 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.86113481 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85957566 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84587086 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82735189 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81991136 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80632815 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80362950 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79879796 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78414679 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76684582 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72571290 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71577590 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71398305 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70234259 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68236574 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65643841 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64829213 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63115940 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63023784 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62574012 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62511726 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60722774 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60280732 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60159508 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.59245840 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.57904718 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57868969 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57606793 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57540589 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57099359 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56730126 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.56568088 |
| 89 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55546958 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54176423 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.53482820 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53228509 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53203159 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53132023 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52927559 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51870532 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51703373 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.50602948 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.50040777 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.49445867 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48814285 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47872307 |
| 103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47108375 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46818277 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45899916 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45403562 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42801155 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42795808 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.42510775 |
| 110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41606543 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41413985 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39990352 |
| 113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39936251 |
| 114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39776937 |
| 115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39744495 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38969049 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.38207889 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37690432 |
| 119 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37509009 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37079377 |
| 121 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37003063 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.33394527 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32691259 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32552538 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31835805 |
| 126 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31161497 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29246555 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26179530 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25048343 |
| 130 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.22159334 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21897725 |

